Superselective catheterization of the prostatic arteries during X-ray endovascular treatment of benign prostatic hyperplasia: A clinical case report

The article presents the clinical case of a 50-year-old patient with stage 2 benign prostatic hyperplasia and acute urinary retention. He had been experiencing lower urinary tract symptoms for almost three years and was undergoing medication without any clinical improvement. The patient underwent embolization of the prostatic arteries using digital imaging technologies for detailed determination of the vascular anatomy of the pelvis and verification of the prostatic arteries. Benign prostatic hyperplasia (BPH) is one of the most common benign urological diseases of a polyetiological nature in men, leading to obstruction of the lower urinary tract. Due to intraand postoperative complications associated with surgical treatment of BPH, such as bleeding, infection, TUR syndrome (a complication of transurethral resection), urinary incontinence, urethral stricture, erectile dysfunction, and retrograde ejaculation, there has been an increased interest in less invasive interventions. Unlike surgical treatment, prostatic artery embolization (PAE) has the advantage of being a minimally invasive procedure with a short hospital stay and early mobilization, and a low risk of serious complications. However, the procedure is technically challenging due to the complex anatomy of the pelvic vessels. To accurately identify the prostatic arteries and minimize the risk of complications, it is optimal to use high-resolution imaging techniques to assess the vascular anatomy in detail and improve the outcome of the procedure.

1. Лопаткин НА (ред.). Урология. М.: ГЭОТАР-Медиа; 2013. 1024 с.

2. Russo GI, Kurbatov D, Sansalone S, Lepetukhin A, Dubsky S, Sitkin I et al. Prostatic Arterial Embolization vs Open Prostatectomy: A 1-Year Matchedpair Analysis of Functional Outcomes and Morbidities. Urology. 2015;86(2):343–348. https://doi.org/10.1016/j.urology.2015.04.037.

3. Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361:k2338. https://doi.org/10.1136/bmj.k2338.

4. Cui L, Bai Y, Zhang J, Yuan B, Wang X, Wang Y et al. Prostatic artery embolization: Progress and prospect. J Interv Med. 2020;3(2):77–79. https://doi.org/10.1016/j.jimed.2020.03.003.

5. Kiemeneij F, Laarman GJ. Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn. 1993;30(2):173–178. https://doi.org/10.1002/ccd.1810300220.

6. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn. 1989;16(1):3–7. https://doi.org/10.1002/ccd.1810160103.

7. Thakor AS, Alshammari MT, Liu DM, Chung J, Ho SGF, Legiehn GM et al. Transradial Access for Interventional Radiology: Single-Centre Procedural and Clinical Outcome Analysis. Can Assoc Radiol J. 2017;68(3):318–327. https://doi.org/10.1016/j.carj.2016.09.003.

8. Resnick NJ, Kim E, Patel RS, Lookstein RA, Nowakowski FS, Fischman AM. Uterine artery embolization using a transradial approach: initial experience and technique. J Vasc Interv Radiol. 2014;25(3):443–447. https://doi.org/10.1016/j.jvir.2013.11.010.

9. Khayrutdinov ER, Gromov DG, Arablinskiy AV, Vorontsov IM, Leonov OV, Kalchenko EA, Ignatev YT. Application of transradial and transfemoral accesses during hepatic artery chemoembolization in the treatment of patients with malignant liver neoplasms. Ural Medical Journal. 2023;22(5):77–86. (In Russ.) https://doi.org/10.52420/2071-5943-2023-22-5-77-86.

10. Khayrutdinov ER, Vorontsov IM, Zharikov SB, Arablinskiy AV, Ignatiev YT, Leonov OV. The advantage of the transradial approach for prostate artery embolization. Russian Journal of Oncology. 2017;22(2):84–88. (In Russ.) https://doi.org/10.18821/1028-9984-2017-22-2-84-88.

11. Stavroulakis K, Usai MV, Torsello G, Schwindt A, Stachmann A, Beropoulis E, Bisdas T. Efficacy and Safety of Transbrachial Access for Iliac Endovascular Interventions. J Endovasc Ther. 2016;23(3):454–460. https://doi.org/10.1177/1526602816640522.

12. Bilhim T, Casal D, Furtado A, Pais D, O’Neill JE, Pisco JM. Branching patterns of the male internal iliac artery: imaging findings. Surg Radiol Anat. 2011;33(2):151–159. https://doi.org/10.1007/s00276-010-0716-3.

13. DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000;11(6):767–770. https://doi.org/10.1016/s1051-0443(07)61638-8.

14. Carnevale FC, Antunes AA, da Motta Leal Filho JM, de Oliveira Cerri LM, Baroni RH, Marcelino AS et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361. https://doi.org/10.1007/s00270-009-9727-z.

15. Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino AS, Cerri LM et al. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol. 2013;24(4):535–542. https://doi.org/10.1016/j.jvir.2012.12.019.

16. Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol. 2016;39(1):44–52. https://doi.org/10.1007/s00270-015-1202-4.

17. Carnevale FC, Antunes AA. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Intervent Radiol. 2013;36(6):1452–1463. https://doi.org/10.1007/s00270-013-0680-5.

18. Delazar S, Azadnajafabad S, Firouznia K, Nowroozi MR, Amini E, Fotouhi M, Ghanaati H. Outcomes of Prostatic Artery Embolization for Treating Benign Prostatic Hyperplasia Symptoms: A Prospective Single-Center Study. Health Sci Rep. 2025;8(3):e70565. https://doi.org/10.1002/hsr2.70565.

19. Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2011;22(1):11–19. https://doi.org/10.1016/j.jvir.2010.09.030.

20. Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;266(2):668–677. https://doi.org/10.1148/radiol.12111601.

21. Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV et al. Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients. J Vasc Interv Radiol. 2016;27(8):1115–1122. https://doi.org/10.1016/j.jvir.2016.04.001.

22. Christidis D, Clarebrough E, Ly V, Perera M, Woo H, Lawrentschuk N, Bolton D. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy. World J Urol. 2018;36(4):575–584. https://doi.org/10.1007/s00345-018-2220-z.

23. Zumstein V, Betschart P, Vetterlein MW, Kluth LA, Hechelhammer L, Mordasini L et al. Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. Eur Urol Focus. 2019;5(6):1091–1100. https://doi.org/10.1016/j.euf.2018.09.005.

24. Moulin B, Di Primio M, Vignaux O, Sarrazin JL, Angelopoulos G, Hakime A. Prostate Artery Embolization: Challenges, Tips, Tricks, and Perspectives. J Pers Med. 2022;13(1):87. https://doi.org/10.3390/jpm13010087.

25. Zharikov SB, Roslik SS, Tsymbal EV, Ivanov VA, Kochetov AG, Esipov AV et al. Short- and long-term outcomes of selective prostatic artery embolization in patient high surgical and anestesilogical risk. RUDN Journal of Medicine. 2017;21(2):270–280. (In Russ.) https://doi.org/10.22363/2313-0245-2017-21-2-270-280.

26. Khunte M, Gaupp FML. Anatomy for Prostatic Artery Embolization. Semin Intervent Radiol. 2025;42(2):213–218. https://doi.org/10.1055/s-0045-1804908.

27. Șerbănoiu A, Nechifor R, Marinescu AN, Iana G, Bratu AM, Sălcianu IA et al. Prostatic Artery Origin Variability: Five Steps to Improve Identification during Percutaneous Embolization. Medicina. 2023;59(12):2122. https://doi.org/10.3390/medicina59122122.

28. Kapranov SA, Zlatovratsky AG, Karpov VK, Shaparov BM, Kamalov AA. Types of the prostate blood supply during super-selective embolization of prostatic arteries. Vestnik Urologii. 2021;9(3):32–43. (In Russ.) https://doi.org/10.21886/2308-6424-2021-9-3-32-43.

29. Xu Z, Zhou Z, Mu Y, Cai T, Gao Z, Liu L. An Updated Meta-Analysis of the Efficacy and Safety of Prostatic Artery Embolization vs. Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Front Surg. 2021;8:779571. https://doi.org/10.3389/fsurg.2021.779571.

30. Altman R, Ferreira R, Barragan C, Bhojani N, Lajkosz K, Zorn KC et al. Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis. BMC Urol. 2024;24(1):22. https://doi.org/10.1186/s12894-023-01397-1.

31. Wang MQ, Duan F, Yuan K, Zhang GD, Yan J, Wang Y. Benign Prostatic Hyperplasia: Cone-Beam CT in Conjunction with DSA for Identifying Prostatic Arterial Anatomy. Radiology. 2017;282(1):271–280. https://doi.org/10.1148/radiol.2016152415.

32. Rostambeigi N, Crawford D, Golzarian J. Benefits and advances of Cone Beam CT use in prostatic artery embolization: review of the literature and pictorial essay. CVIR Endovasc. 2024;7(1):46. https://doi.org/10.1186/s42155-024-00459-1.

33. Carnevale FC, McClure T, Cadour F, Vidal V, de Assis AM, Moreira AM et al. Advanced image guidance for prostatic artery embolization – a multicenter technical note. CVIR Endovasc. 2021;4(1):63. https://doi.org/10.1186/s42155-021-00249-z.

34. Skryabin ES, Khanaliev BV, Maslennikov MA, Marchak DI. Prostatic artery embolization in benign prostatic hyperplasia. Bulletin of Pirogov National Medical & Surgical Center. 2022;17(2):95–102. (In Russ.) https://doi.org/10.25881/20728255_2022_17_2_95.

35. Dung LT, Hung ND, Thien LQ, Huyen DK, Vu LN, Hung DD, Duc NM. Dualenergy computed tomography in supporting prostatic artery embolization for benign prostatic hyperplasia. Int J Med Sci. 2024;21(9):1640–1648. https://doi.org/10.7150/ijms.96319.

36. Klimov VP, Azarov AV, Semitko SP, Vertkina NV. Rotational angiography and the role of rotational angiography in modern clinical practice. Consilium Medicum. 2017;19(1):42–49. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/94657.

37. Bilhim T, Costa NV, Torres D, Pinheiro LC, Spaepen E. Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period. Cardiovasc Intervent Radiol. 2022;45(9):1324–1336. https://doi.org/10.1007/s00270-022-03199-8.